A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

NCT07577843 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

460

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn Disease

Interventions

DRUG: JNJ-78934804
DRUG: Guselkumab

Sponsor

Janssen Research & Development, LLC